A carregar...
The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial
OBJECTIVES: Dexmedetomidine, a highly selective central α(2)-agonist, undergoes mainly biotransformation in the liver. The pharmacokinetics of dexmedetomidine were significantly affected by hepatic insufficiency. The clearance of dexmedetomidine in patients with severe hepatic failure decreased by 5...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6235379/ https://ncbi.nlm.nih.gov/pubmed/30427948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0207427 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|